SCHEMBL17591499

SCHEMBL17591499

Cc1cccc(-c2cc3cn2-3)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.44
▸ L3MBTL1 Q9Y468 4/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ HPGD P15428 2/20 0.42
▸ PPARG P37231 1/20 0.42
▸ NCOA2 Q15596 1/20 0.42
▸ NCOA1 Q15788 1/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ RAB9A P51151 5/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ MGLL Q99685 1/20 0.41
▸ NISCH Q9Y2I1 1/20 0.41
▸ NPC1 O15118 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ ADRB1 P08588 1/20 0.39
▸ TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31471473 0.74 ACHE (0.69) ACHEALDH1A1HPGDKMT2AMEN1
SCHEMBL29373699 0.74 ACHE (0.69) ACHEALDH1A1HPGDKMT2AMEN1
SCHEMBL301247 0.74 ACHE (0.69) ACHEALDH1A1HPGDKMT2AMEN1
SCHEMBL12279036 0.72 HPGD (0.42) ACHEL3MBTL1ALDH1A1HPGDKMT2A
SCHEMBL11663415 0.72 KMT2A (0.71) L3MBTL1ALDH1A1HPGDKMT2AMEN1
SCHEMBL18797759 0.71 ACHE (0.65) ACHEALDH1A1HPGDKMT2AMEN1
SCHEMBL19577801 0.71 ACHE (0.65) ACHEALDH1A1HPGDKMT2AMEN1
SCHEMBL10429722 0.71 L3MBTL1 (0.48) L3MBTL1ALDH1A1KMT2ARAB9ANPC1
SCHEMBL25077726 0.71 TLR8 (0.42) ACHEALDH1A1KMT2AMEN1RAB9A
SCHEMBL12279326 0.70 KMT2A (0.38) ACHEL3MBTL1KMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2776430-B1 2- (1,2,3-TRIAZOL-2-YL) BENZAMIDE AND 3-(1,2,3-TRIAZOL-2-YL) PICOLINAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2016-03-16 — — EP disclosed
Send feedback